
Enblo’s Global Expansion Milestone: Daewoong Pharmaceutical’s Strategic Pursuit
Daewoong Pharmaceutical announced on April 18th that it has completed the application for approval of Enblo (active ingredient: Inavogliflozin) in a total of seven countries, including six Latin American countries—Costa Rica, Honduras, the Dominican …